glp-1 and alzheimer's PDF] Novel dual GLP-1/GIP receptor agonists show neuroprotective effects in Parkinson's disease models The mechanism of action of
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
![glp-1 and alzheimer's PDF] Novel dual GLP-1/GIP receptor agonists show neuroprotective effects in Parkinson's disease models The mechanism of action of](https://ars.els-cdn.com/content/image/1-s2.0-S0024320520313989-ga1.jpg)
![glp-1 and alzheimer's PDF] Novel dual GLP-1/GIP receptor agonists show neuroprotective effects in Parkinson's disease models The mechanism of action of](https://ars.els-cdn.com/content/image/1-s2.0-S0006295221001842-ga1.jpg)
![glp-1 and alzheimer's PDF] Novel dual GLP-1/GIP receptor agonists show neuroprotective effects in Parkinson's disease models The mechanism of action of](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12929-024-01090-x/MediaObjects/12929_2024_1090_Fig2_HTML.png)
![glp-1 and alzheimer's PDF] Novel dual GLP-1/GIP receptor agonists show neuroprotective effects in Parkinson's disease models The mechanism of action of](https://ars.els-cdn.com/content/image/1-s2.0-S1871402117304782-gr2.jpg)
![glp-1 and alzheimer's PDF] Novel dual GLP-1/GIP receptor agonists show neuroprotective effects in Parkinson's disease models The mechanism of action of](https://www.cell.com/cms/10.1016/j.xcrm.2025.102511/asset/bd5f7d8c-9df3-4233-b624-bd5bc95bbde3/main.assets/fx1_lrg.jpg)




















